# Real-world Effectiveness and Tolerability of Triptans-Ditans-Gepants (TRIDIGEP)

> **NCT06267664** · — · UNKNOWN · sponsor: **Hospital Clínico Universitario de Valladolid** · enrollment: 1500 (estimated)

## Conditions studied

- Migraine
- Migraine Disorders
- Migraine With Aura
- Headache Disorders

## Interventions

- **DRUG:** Patients with migraine treated with triptans, Lasmiditan or Gepants

## Key facts

- **NCT ID:** NCT06267664
- **Lead sponsor:** Hospital Clínico Universitario de Valladolid
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12-04
- **Primary completion:** 2024-09-30
- **Final completion:** 2024-12-01
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2024-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06267664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06267664, "Real-world Effectiveness and Tolerability of Triptans-Ditans-Gepants (TRIDIGEP)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06267664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*